Targeting the sphingosine 1-phosphate receptor 2 for multiple sclerosis computer-aided drug discovery
Multiple sclerosis (MS) continues to affect 2.8 million people worldwide in 2020, and as of yet there is no cure for it. There exist drugs to treat the symptoms of MS, but those that aim to treat the cause of the disease are scarce, as it affects the autoimmune response, and little is known about di...
Saved in:
Main Authors: | Dalmacio, Jeremy V., Tanada, Noah Rafael Moran |
---|---|
Format: | text |
Language: | English |
Published: |
Animo Repository
2022
|
Subjects: | |
Online Access: | https://animorepository.dlsu.edu.ph/etdb_chem/23 https://animorepository.dlsu.edu.ph/cgi/viewcontent.cgi?article=1026&context=etdb_chem |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | De La Salle University |
Language: | English |
Similar Items
-
People with multiple sclerosis : condition, challenges and care
by: Bull, Paul J.
Published: (2020) -
Toward precision phenotyping of multiple sclerosis
by: Pitt, David, et al.
Published: (2023) -
Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration
by: James, Rachel E., et al.
Published: (2021) -
Dimethyl fumarate reduces inflammation in chronic active multiple sclerosis lesions
by: Zinger, Nicole, et al.
Published: (2023) -
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients : early involvement in compartmentalised intrathecal inflammation
by: Magliozzi, Roberta, et al.
Published: (2021)